U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular disorder, according to a letter provided by his office to Reuters. The drug is now sold at a list price of $…
The post Senator Sanders urges FDA to allow older versions of $375K drug appeared first on Raw Story.
Droolin’ Dog sniffed out this story and shared it with you.
The Article Was Written/Published By: Reuters